发明名称 |
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method |
摘要 |
A device is disclosed for conducting a non-invasive analysis of a bodily fluid to determine the presence and level of a certain constituent carried by the bodily fluid. An indicator formulation of the device changes color in response to exposure to the constituent to provide a visible indication of the presence and level of the constituent carried by the bodily fluid. A carrier substrate of the device is constructed of a material having voids providing a high void volume within the substrate. The device is made by applying a chromagen to the carrier substrate to create a chromagen-laden carrier member. Then, a selected reagent having a particular constituent-specific formulation is applied to the chromagen-laden member. The selected reagent then combines with the chromagen thereby establishing the indicator formulation within the carrier substrate in place for reception of a sample of the bodily fluid. |
申请公布号 |
US9562256(B2) |
申请公布日期 |
2017.02.07 |
申请号 |
US201615155803 |
申请日期 |
2016.05.16 |
申请人 |
Pop Test LLC |
发明人 |
Altschul Randice Lisa;Theise Neil David;Rapkin Myron;O'Brien Rebecca |
分类号 |
G01N21/78;C12Q1/52;G01N21/29;G01N33/52;G01N33/558;G01N33/574;G01N33/66;G01N33/92;G01N21/75 |
主分类号 |
G01N21/78 |
代理机构 |
|
代理人 |
Jacob Arthur |
主权项 |
1. A method of making a device for conducting a non-invasive analysis of a bodily fluid to determine the presence and the level of a certain constituent carried by the bodily fluid, the device including an indicator formulation capable of changing color in response to exposure to the certain constituent to provide a visible indication of the presence and the level of the certain constituent carried by the bodily fluid, the method comprising:
providing a carrier substrate of a material having voids establishing a high void volume within the carrier substrate, the carrier substrate having a total volume and the high void volume being within a range of about eight to twelve percent of the total volume; applying a chromagen formulation to the carrier substrate to create a chromagen-laden carrier member; and subsequently applying to the chromagen-laden carrier member a selected reagent having a particular constituent-specific formulation to combine the selected reagent with the chromagen formulation applied to the carrier substrate, thereby establishing the indicator formulation within the carrier substrate in place for reception of a sample of the bodily fluid later placed upon the carrier substrate; wherein the different certain constituents are alanine aminotransferase (ALT) and aspartame aminotransferase (AST). |
地址 |
Cliffside Park NJ US |